Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson’s Disease

Roberta Ferrucci, Francesca Cortese, Marta Bianchi, Dario Pittera, Rosanna Turrone, Tommaso Bocci, Barbara Borroni, Maurizio Vergari, Filippo Cogiamanian, Gianluca Ardolino, Alessio Di Fonzo, Alessandro Padovani, Alberto Priori

Research output: Contribution to journalArticle

Abstract

Transcranial direct current stimulation (tDCS) is a non-invasive technique for inducing prolonged functional changes in the human cerebral cortex. This simple and safe neurostimulation technique for modulating motor functions in Parkinson’s disease could extend treatment option for patients with movement disorders. We assessed whether tDCS applied daily over the cerebellum (cerebellar tDCS) and motor cortex (M1-tDCS) improves motor and cognitive symptoms and levodopa-induced dyskinesias in patients with Parkinson’s disease (PD). Nine patients (aged 60–85 years; four women; Hoehn & Yahr scale score 2–3) diagnosed as having idiopathic PD were recruited. To evaluate how tDCS (cerebellar tDCS or M1-tDCS) affects motor and cognitive function in PD, we delivered bilateral anodal (2 mA, 20 min, five consecutive days) and sham tDCS, in random order, in three separate experimental sessions held at least 1 month apart. In each session, as outcome variables, patients underwent the Unified Parkinson’s Disease Rating Scale (UPDRS III and IV) and cognitive testing before treatment (baseline), when treatment ended on day 5 (T1), 1 week later (T2), and then 4 weeks later (T3), at the same time each day. After patients received anodal cerebellar tDCS and M1-tDCS for five days, the UPDRS IV (dyskinesias section) improved (p <0.001). Conversely, sham tDCS, cerebellar tDCS, and M1-tDCS left the other variables studied unchanged (p > 0.05). Despite the small sample size, our preliminary results show that anodal tDCS applied for five consecutive days over the motor cortical areas and cerebellum improves parkinsonian patients’ levodopa-induced dyskinesias.

Original languageEnglish
Pages (from-to)43-47
Number of pages5
JournalCerebellum
Volume15
Issue number1
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Dyskinesias
Levodopa
Parkinson Disease
Motor Cortex
Cerebellum
Transcranial Direct Current Stimulation
Neurobehavioral Manifestations
Movement Disorders
Cerebral Cortex
Sample Size
Cognition
Therapeutics

Keywords

  • Cerebellar tDCS
  • Cerebellum
  • Levodopa-induced dyskinesias
  • Parkinson
  • tDCS

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson’s Disease. / Ferrucci, Roberta; Cortese, Francesca; Bianchi, Marta; Pittera, Dario; Turrone, Rosanna; Bocci, Tommaso; Borroni, Barbara; Vergari, Maurizio; Cogiamanian, Filippo; Ardolino, Gianluca; Di Fonzo, Alessio; Padovani, Alessandro; Priori, Alberto.

In: Cerebellum, Vol. 15, No. 1, 01.02.2016, p. 43-47.

Research output: Contribution to journalArticle

Ferrucci, Roberta ; Cortese, Francesca ; Bianchi, Marta ; Pittera, Dario ; Turrone, Rosanna ; Bocci, Tommaso ; Borroni, Barbara ; Vergari, Maurizio ; Cogiamanian, Filippo ; Ardolino, Gianluca ; Di Fonzo, Alessio ; Padovani, Alessandro ; Priori, Alberto. / Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson’s Disease. In: Cerebellum. 2016 ; Vol. 15, No. 1. pp. 43-47.
@article{a58bb3d3e547460d9a61c81f3c75e044,
title = "Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson’s Disease",
abstract = "Transcranial direct current stimulation (tDCS) is a non-invasive technique for inducing prolonged functional changes in the human cerebral cortex. This simple and safe neurostimulation technique for modulating motor functions in Parkinson’s disease could extend treatment option for patients with movement disorders. We assessed whether tDCS applied daily over the cerebellum (cerebellar tDCS) and motor cortex (M1-tDCS) improves motor and cognitive symptoms and levodopa-induced dyskinesias in patients with Parkinson’s disease (PD). Nine patients (aged 60–85 years; four women; Hoehn & Yahr scale score 2–3) diagnosed as having idiopathic PD were recruited. To evaluate how tDCS (cerebellar tDCS or M1-tDCS) affects motor and cognitive function in PD, we delivered bilateral anodal (2 mA, 20 min, five consecutive days) and sham tDCS, in random order, in three separate experimental sessions held at least 1 month apart. In each session, as outcome variables, patients underwent the Unified Parkinson’s Disease Rating Scale (UPDRS III and IV) and cognitive testing before treatment (baseline), when treatment ended on day 5 (T1), 1 week later (T2), and then 4 weeks later (T3), at the same time each day. After patients received anodal cerebellar tDCS and M1-tDCS for five days, the UPDRS IV (dyskinesias section) improved (p <0.001). Conversely, sham tDCS, cerebellar tDCS, and M1-tDCS left the other variables studied unchanged (p > 0.05). Despite the small sample size, our preliminary results show that anodal tDCS applied for five consecutive days over the motor cortical areas and cerebellum improves parkinsonian patients’ levodopa-induced dyskinesias.",
keywords = "Cerebellar tDCS, Cerebellum, Levodopa-induced dyskinesias, Parkinson, tDCS",
author = "Roberta Ferrucci and Francesca Cortese and Marta Bianchi and Dario Pittera and Rosanna Turrone and Tommaso Bocci and Barbara Borroni and Maurizio Vergari and Filippo Cogiamanian and Gianluca Ardolino and {Di Fonzo}, Alessio and Alessandro Padovani and Alberto Priori",
year = "2016",
month = "2",
day = "1",
doi = "10.1007/s12311-015-0737-x",
language = "English",
volume = "15",
pages = "43--47",
journal = "Cerebellum",
issn = "1473-4222",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson’s Disease

AU - Ferrucci, Roberta

AU - Cortese, Francesca

AU - Bianchi, Marta

AU - Pittera, Dario

AU - Turrone, Rosanna

AU - Bocci, Tommaso

AU - Borroni, Barbara

AU - Vergari, Maurizio

AU - Cogiamanian, Filippo

AU - Ardolino, Gianluca

AU - Di Fonzo, Alessio

AU - Padovani, Alessandro

AU - Priori, Alberto

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Transcranial direct current stimulation (tDCS) is a non-invasive technique for inducing prolonged functional changes in the human cerebral cortex. This simple and safe neurostimulation technique for modulating motor functions in Parkinson’s disease could extend treatment option for patients with movement disorders. We assessed whether tDCS applied daily over the cerebellum (cerebellar tDCS) and motor cortex (M1-tDCS) improves motor and cognitive symptoms and levodopa-induced dyskinesias in patients with Parkinson’s disease (PD). Nine patients (aged 60–85 years; four women; Hoehn & Yahr scale score 2–3) diagnosed as having idiopathic PD were recruited. To evaluate how tDCS (cerebellar tDCS or M1-tDCS) affects motor and cognitive function in PD, we delivered bilateral anodal (2 mA, 20 min, five consecutive days) and sham tDCS, in random order, in three separate experimental sessions held at least 1 month apart. In each session, as outcome variables, patients underwent the Unified Parkinson’s Disease Rating Scale (UPDRS III and IV) and cognitive testing before treatment (baseline), when treatment ended on day 5 (T1), 1 week later (T2), and then 4 weeks later (T3), at the same time each day. After patients received anodal cerebellar tDCS and M1-tDCS for five days, the UPDRS IV (dyskinesias section) improved (p <0.001). Conversely, sham tDCS, cerebellar tDCS, and M1-tDCS left the other variables studied unchanged (p > 0.05). Despite the small sample size, our preliminary results show that anodal tDCS applied for five consecutive days over the motor cortical areas and cerebellum improves parkinsonian patients’ levodopa-induced dyskinesias.

AB - Transcranial direct current stimulation (tDCS) is a non-invasive technique for inducing prolonged functional changes in the human cerebral cortex. This simple and safe neurostimulation technique for modulating motor functions in Parkinson’s disease could extend treatment option for patients with movement disorders. We assessed whether tDCS applied daily over the cerebellum (cerebellar tDCS) and motor cortex (M1-tDCS) improves motor and cognitive symptoms and levodopa-induced dyskinesias in patients with Parkinson’s disease (PD). Nine patients (aged 60–85 years; four women; Hoehn & Yahr scale score 2–3) diagnosed as having idiopathic PD were recruited. To evaluate how tDCS (cerebellar tDCS or M1-tDCS) affects motor and cognitive function in PD, we delivered bilateral anodal (2 mA, 20 min, five consecutive days) and sham tDCS, in random order, in three separate experimental sessions held at least 1 month apart. In each session, as outcome variables, patients underwent the Unified Parkinson’s Disease Rating Scale (UPDRS III and IV) and cognitive testing before treatment (baseline), when treatment ended on day 5 (T1), 1 week later (T2), and then 4 weeks later (T3), at the same time each day. After patients received anodal cerebellar tDCS and M1-tDCS for five days, the UPDRS IV (dyskinesias section) improved (p <0.001). Conversely, sham tDCS, cerebellar tDCS, and M1-tDCS left the other variables studied unchanged (p > 0.05). Despite the small sample size, our preliminary results show that anodal tDCS applied for five consecutive days over the motor cortical areas and cerebellum improves parkinsonian patients’ levodopa-induced dyskinesias.

KW - Cerebellar tDCS

KW - Cerebellum

KW - Levodopa-induced dyskinesias

KW - Parkinson

KW - tDCS

UR - http://www.scopus.com/inward/record.url?scp=84955755919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955755919&partnerID=8YFLogxK

U2 - 10.1007/s12311-015-0737-x

DO - 10.1007/s12311-015-0737-x

M3 - Article

AN - SCOPUS:84955755919

VL - 15

SP - 43

EP - 47

JO - Cerebellum

JF - Cerebellum

SN - 1473-4222

IS - 1

ER -